In the News
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Twist Bioscience Corporation, a company that offers high-quality synthetic DNA using its silicon platform, along with Aster Insights, has announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620...
Clinical ink Announces New Continuous Glucose Monitoring Solution
Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The...
RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials
Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in...
Inside the new world of healthcare data
In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. The discussion began with data...
Replica Analytics unveils Replica Synthesis 3.0
Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and evaluate their utility and privacy. The company...
M2GEN Rebrands to Aster Insights
Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for researchers and accelerated target identification and drug...
Through reverse auctions, Minnesota pushes for PBM savings and price transparency
Truveris has helped the State of Minnesota save more than $28 million in pharmacy benefits expenses over the next two years. Using the company’s technology, the state was able to evaluate bids from competing pharmacy benefit managers (PBMs). Truveris’ technology allows health plan sponsors to conduct reverse...
Matternet Tests Longest Drone Delivery Route Between Hospitals and Labs in Switzerland
Matternet has begun test operations on a 5-kilometer (3-mile) beyond visual line of sight (BVLOS) drone delivery route over Zurich, Switzerland. This is the longest urban drone delivery route ever, and it still takes only seven minutes for drones to go from one facility to the other—a much shorter time than it would...
Matternet Set to Produce M2 Delivery Drones in the US After Receiving FAA Greenlight
Matternet’s groundbreaking FAA Type Certification for its M2 drone in September of 2022 was followed quickly by being granted a Production Certificate for the craft by the US Federal Aviation Administration. With the Production Certificate, Matternet can now begin mass production of its M2 drone at its factory in...
Running Through Walls: Thinking Long Term is the Greatest Gift
In a recent Venrock podcast, Aledade Founder and CEO Farzad Mostashari spoke about how to heighten the efficiency and effectiveness of patient care, specifically preventative care. He discusses how Aledade is working to help patients when average primary care practices can’t and the new launch of Aledade Care...